tiprankstipranks
Trending News
More News >
Akero Therapeutics Inc (AKRO)
NASDAQ:AKRO
US Market
Advertisement

Akero Therapeutics (AKRO) Technical Analysis

Compare
641 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
6Neutral
1Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Akero Therapeutics Inc’s (AKRO) Moving Averages Convergence Divergence (MACD) indicator is 0.68, suggesting Akero Therapeutics Inc is a Buy.
Akero Therapeutics Inc’s (AKRO) 20-Day exponential moving average is 53.90, while Akero Therapeutics Inc’s (AKRO) share price is $54.36, making it a Buy.
Akero Therapeutics Inc’s (AKRO) 50-Day exponential moving average is 52.19, while Akero Therapeutics Inc’s (AKRO) share price is $54.36, making it a Buy.

Akero Therapeutics (AKRO) Pivot Points

Nov 26, 2025, 02:45 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
54.17
54.22
54.26
54.31
54.35
54.40
54.44
Fibonacci
54.22
54.25
54.27
54.31
54.34
54.36
54.40
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Akero Therapeutics (AKRO) Moving Averages

Nov 26, 2025, 02:45 PM
Period
Simple
Exponential
MA5
54.31Buy
54.31Buy
MA10
54.29Buy
54.26Buy
MA20
54.18Buy
53.90Buy
MA50
51.35Buy
52.19Buy
MA100
50.04Buy
50.34Buy
MA200
47.98Buy
46.85Buy
Akero Therapeutics Inc’s (AKRO) 10-Day exponential moving average is 54.26, while Akero Therapeutics Inc’s (AKRO) share price is $54.36, making it a Buy.
Akero Therapeutics Inc’s (AKRO) 100-Day exponential moving average is 50.34, while Akero Therapeutics Inc’s (AKRO) share price is $54.36, making it a Buy.
Akero Therapeutics Inc’s (AKRO) stock price is $54.36 and Akero Therapeutics Inc’s (AKRO) 50-day simple moving average is 51.35, creating a Buy signal.
Akero Therapeutics Inc’s (AKRO) stock price is $54.36 and Akero Therapeutics Inc’s (AKRO) 100-day simple moving average is 50.04, creating a Buy signal.
Akero Therapeutics Inc’s (AKRO) stock price is $54.36 and Akero Therapeutics Inc’s (AKRO) 200-day simple moving average is 47.98, creating a Buy signal.

Akero Therapeutics (AKRO) Technical Indicators

Nov 26, 2025, 02:45 PM
Name
Value
Implied Action
RSI (14)
67.72
Neutral
STOCH (9,6)
69.88
Neutral
STOCHRSI (14)
79.21
Neutral
MACD (12,26)
0.68
Buy
ADX (14)
35.79
Neutral
Williams %R
-8.91
Sell
CCI (14)
97.15
Neutral
ATR (14)
0.37
-
Ultimate Oscillator
50.51
Neutral
ROC
0.61
Buy
Akero Therapeutics Inc’s (AKRO) Relative Strength Index (RSI) is 67.72, creating a Neutral signal.
Akero Therapeutics Inc’s (AKRO) Trend Strength Indicator (ADX) is 35.79, creating a Neutral signal.
Akero Therapeutics Inc’s (AKRO) Commodity Channel Index (CCI) is 97.15, creating a Neutral signal.
Akero Therapeutics Inc’s (AKRO) Price Rate of Change (ROC) is 0.61, creating a Buy signal.

FAQ

Is AKRO a Buy, Hold, or Sell?
Based on AKRO’s technical indicators, AKRO is a Strong Buy.
    What is AKRO’s RSI (14)?
    AKRO’s RSI (14) is 67.72, which suggests AKRO is a Neutral.
      What is AKRO’s MACD?
      AKRO’s MACD is 0.68, which suggests AKRO is a Buy.
        What is AKRO’s 5-day moving average?
        AKRO’s 5-day moving average is 54.31, which suggests AKRO is a Buy.
          What is AKRO’s 20-day moving average?
          AKRO 20-day moving average is 54.18, which suggests AKRO is a Buy.
            What is AKRO’s 50-day moving average?
            AKRO’s 50-day moving average is 51.35, which suggests AKRO is a Buy.
              What is AKRO’s 200-day moving average?
              AKRO’s 200-day moving average is 47.98, which suggests AKRO is a Buy.
                What is AKRO’s Williams % R (14)?
                AKRO’s Williams % R (14) is -8.91, which suggests AKRO is a Sell.
                  What is AKRO’s CCI (14)?
                  AKRO’s CCI (14) is 97.15, which suggests AKRO is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis